By March 2009, screening will be offered for the metabolic disorder Medium Chain Acyl CoA Dehydrogenase Deficiency (MCADD) as part of standard newborn screening within England. MCADD is an autosomal recessive genetic disorder that results in an impaired ability to maintain normal blood sugar levels during metabolic stress; the condition is associated with high death rates and severe neurological damage in affected children. Once the condition has been identified, treatment through dietary management can reduce the risk of death and the risk of acute, serious illness.
Public Health Genetics Unit – News: http://www.phgu.org.uk/ecard?link_ID=3114
For more information on Newborn Screening and the other conditions curently tested for: http://www.newbornscreening-bloodspot.org.uk/